ScPharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 150

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $421M

ScPharmaceuticals General Information

Description

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 25 Mall Road
  • Suite 203
  • Burlington, MA 01803
  • United States
+1 (617)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Discovery Tools (Healthcare)
Medical Supplies
Parent Company
Corporate Office
  • 25 Mall Road
  • Suite 203
  • Burlington, MA 01803
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ScPharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 07-Oct-2025 $421M Completed Generating Revenue
8. 2PO 13-Aug-2024 Completed Generating Revenue
7. Debt Refinancing 12-Aug-2024 Completed Generating Revenue
6. General Corporate Purpose 11-Oct-2022 Completed Generating Revenue
5. 2PO 22-May-2020 Completed Generating Revenue
4. IPO 17-Nov-2017 Completed Generating Revenue
3. Debt - General 23-May-2017 Completed Generating Revenue
2. Early Stage VC (Series B) 23-Dec-2016 $45.6M $69.8M Completed Generating Revenue
1. Early Stage VC (Series A) 15-Jun-2016 $24.2M $24.2M Completed Generating Revenue
To view ScPharmaceuticals’s complete valuation and funding history, request access »

ScPharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view ScPharmaceuticals’s complete cap table history, request access »

ScPharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the poten
Other Pharmaceuticals and Biotechnology
Burlington, MA
150 As of 2025

Burlington, MA
 

Acton, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ScPharmaceuticals Competitors (5)

One of ScPharmaceuticals’s 5 competitors is SQ Innovation, a Venture Capital-Backed company based in Burlington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SQ Innovation Venture Capital-Backed Burlington, MA
Insulet Formerly VC-backed Acton, MA
Tenaya Therapeutics Formerly VC-backed South San Francisco, CA
Owen Mumford Corporate Backed or Acquired Chipping Norton, United Kingdom
Haselmeier Private Equity-Backed Stuttgart, Germany
You’re viewing 5 of 5 competitors. Get the full list »

ScPharmaceuticals Patents

ScPharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026152113-A1 Furosemide formulations Pending 13-Jan-2025
AU-2024207876-A1 Methods of treatment using loop diuretics Pending 09-Jan-2023
EP-4648761-A1 Methods of treatment using loop diuretics Pending 09-Jan-2023
US-20260232621-A1 Methods of treatment using loop diuretics Pending 09-Jan-2023
WO-2024151502-A1 Methods of treatment using loop diuretics Inactive 09-Jan-2023 A61P7/06
To view ScPharmaceuticals’s complete patent history, request access »

ScPharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ScPharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
5AM Ventures Venture Capital Minority
Gilde Healthcare PE/Buyout Minority
Lundbeckfonden BioCapital Venture Capital Minority
OrbiMed Growth/Expansion Minority
Sun Pharmaceutical Industries Corporation Minority
To view ScPharmaceuticals’s complete investors history, request access »

ScPharmaceuticals ESG

Risk Overview

Risk Rating

Updated June, 30, 2025

39.13 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Pharmaceuticals

Industry

of 908

Rank

Percentile

Pharmaceuticals

Subindustry

of 406

Rank

Percentile

To view ScPharmaceuticals’s complete esg history, request access »

ScPharmaceuticals FAQs

  • When was ScPharmaceuticals founded?

    ScPharmaceuticals was founded in 2013.

  • Where is ScPharmaceuticals headquartered?

    ScPharmaceuticals is headquartered in Burlington, MA.

  • What is the size of ScPharmaceuticals?

    ScPharmaceuticals has 150 total employees.

  • What industry is ScPharmaceuticals in?

    ScPharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is ScPharmaceuticals a private or public company?

    ScPharmaceuticals is a Private company.

  • What is the current valuation of ScPharmaceuticals?

    The current valuation of ScPharmaceuticals is .

  • What is ScPharmaceuticals’s current revenue?

    The current revenue for ScPharmaceuticals is .

  • How much funding has ScPharmaceuticals raised over time?

    ScPharmaceuticals has raised $487M.

  • Who are ScPharmaceuticals’s investors?

    5AM Ventures, Gilde Healthcare, Lundbeckfonden BioCapital, OrbiMed, and Sun Pharmaceutical Industries have invested in ScPharmaceuticals.

  • Who are ScPharmaceuticals’s competitors?

    SQ Innovation, Insulet, Tenaya Therapeutics, Owen Mumford, and Haselmeier are competitors of ScPharmaceuticals.

  • When was ScPharmaceuticals acquired?

    ScPharmaceuticals was acquired on 07-Oct-2025.

  • Who acquired ScPharmaceuticals?

    ScPharmaceuticals was acquired by MannKind.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process